Edwards Lifesciences (EW) Competitors $70.63 +0.76 (+1.09%) Closing price 04/15/2025 03:59 PM EasternExtended Trading$70.38 -0.26 (-0.37%) As of 04/15/2025 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EW vs. BSX, SYK, MDT, BDX, RMD, IDXX, DXCM, STE, PODD, and BAXShould you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), and Baxter International (BAX). These companies are all part of the "health care equipment" industry. Edwards Lifesciences vs. Boston Scientific Stryker Medtronic Becton, Dickinson and Company ResMed IDEXX Laboratories DexCom STERIS Insulet Baxter International Edwards Lifesciences (NYSE:EW) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation. Do institutionals and insiders believe in EW or BSX? 79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 0.5% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to EW or BSX? In the previous week, Edwards Lifesciences had 3 more articles in the media than Boston Scientific. MarketBeat recorded 34 mentions for Edwards Lifesciences and 31 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.34 beat Edwards Lifesciences' score of 1.32 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 25 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 26 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, EW or BSX? Edwards Lifesciences has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Does the MarketBeat Community prefer EW or BSX? Edwards Lifesciences received 280 more outperform votes than Boston Scientific when rated by MarketBeat users. Likewise, 70.82% of users gave Edwards Lifesciences an outperform vote while only 69.72% of users gave Boston Scientific an outperform vote. CompanyUnderperformOutperformEdwards LifesciencesOutperform Votes133770.82% Underperform Votes55129.18% Boston ScientificOutperform Votes105769.72% Underperform Votes45930.28% Which has stronger valuation & earnings, EW or BSX? Edwards Lifesciences has higher earnings, but lower revenue than Boston Scientific. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdwards Lifesciences$5.44B7.64$4.17B$6.9710.14Boston Scientific$16.75B8.29$1.85B$1.2575.07 Do analysts recommend EW or BSX? Edwards Lifesciences currently has a consensus price target of $78.55, indicating a potential upside of 11.17%. Boston Scientific has a consensus price target of $109.04, indicating a potential upside of 16.20%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Boston Scientific is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edwards Lifesciences 1 Sell rating(s) 13 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.38Boston Scientific 0 Sell rating(s) 1 Hold rating(s) 21 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is EW or BSX more profitable? Edwards Lifesciences has a net margin of 72.93% compared to Boston Scientific's net margin of 11.07%. Edwards Lifesciences' return on equity of 19.40% beat Boston Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Edwards Lifesciences72.93% 19.40% 14.37% Boston Scientific 11.07%17.80%9.85% SummaryEdwards Lifesciences beats Boston Scientific on 10 of the 19 factors compared between the two stocks. Remove Ads Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EW vs. The Competition Export to ExcelMetricEdwards LifesciencesSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$41.54B$8.60B$5.32B$18.57BDividend YieldN/A1.71%5.11%4.24%P/E Ratio10.1418.5521.7731.19Price / Sales7.6472.58378.2625.58Price / Cash27.0419.6738.1517.54Price / Book6.384.856.444.30Net Income$4.17B$284.66M$3.20B$1.02B7 Day Performance5.40%5.84%6.42%6.72%1 Month Performance1.86%-2.00%-8.66%-6.76%1 Year Performance-20.78%-21.67%10.27%1.39% Edwards Lifesciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EWEdwards Lifesciences4.5124 of 5 stars$70.63+1.1%$78.55+11.2%-20.8%$41.52B$5.44B10.1317,300Insider TradePositive NewsBSXBoston Scientific4.4238 of 5 stars$91.44+1.9%$108.91+19.1%+39.7%$135.25B$16.75B73.1545,000Upcoming EarningsPositive NewsSYKStryker4.6774 of 5 stars$345.46-0.1%$421.90+22.1%+2.3%$131.86B$22.60B44.5251,000News CoveragePositive NewsHigh Trading VolumeMDTMedtronic4.6713 of 5 stars$83.10+0.3%$96.07+15.6%+2.5%$106.58B$33.20B25.2695,000Short Interest ↓Positive NewsBDXBecton, Dickinson and Company4.8353 of 5 stars$204.88-1.2%$275.71+34.6%-13.9%$58.83B$20.64B34.0377,000Short Interest ↑Analyst RevisionRMDResMed4.4046 of 5 stars$213.06+3.8%$249.73+17.2%+15.6%$31.29B$4.93B25.158,160Analyst UpgradeAnalyst RevisionPositive NewsIDXXIDEXX Laboratories4.8026 of 5 stars$379.05-3.7%$533.75+40.8%-17.8%$30.74B$3.90B35.5510,800Analyst ForecastPositive NewsHigh Trading VolumeDXCMDexCom4.9065 of 5 stars$61.61+3.0%$99.82+62.0%-48.6%$24.16B$4.03B43.097,600Positive NewsSTESTERIS4.6002 of 5 stars$212.62+0.0%$258.75+21.7%+9.9%$20.89B$5.40B45.1416,000Positive NewsPODDInsulet4.5682 of 5 stars$256.10+4.4%$292.06+14.0%+47.4%$17.99B$2.07B44.232,600Short Interest ↓Positive NewsBAXBaxter International4.6088 of 5 stars$28.61-0.6%$38.56+34.8%-30.4%$14.67B$10.64B-22.3560,000 Remove Ads Related Companies and Tools Related Companies Boston Scientific Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives ResMed Alternatives IDEXX Laboratories Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EW) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EW Stock Free EW Stock Alerts